20/20 Biolabs, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $538 | $417 | $536 | $361 |
Gross Profit | 130 | 145 | 163 | 24 |
EBITDA | -780 | -1,217 | -1,856 | |
EBIT | -800 | -1,249 | -1,890 | |
Net Income | -1,307 | -825 | -1,249 | -1,873 |
Net Change In Cash | 538 | 417 | 536 | 361 |
Free Cash Flow | -511 | -536 | ||
Cash | 1,025,987 | 1,144 | 1,784 | |
Basic Shares | 10,347 | 4,856 | 4,804 | 4,804 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,045,133 | $1,752 | $1,424 | $11,059 |
Gross Profit | 604,541 | 360 | 109 | 5,121 |
EBITDA | -3,330,871 | -5,525 | -6,194 | 1,967 |
EBIT | -5,661 | -6,361 | 1,678 | |
Net Income | -3,738,821 | -5,551 | -6,391 | 2,186 |
Net Change In Cash | 2,045,133 | 1,752 | 1,424 | 11,059 |
Free Cash Flow | -1,919,720 | -2,598 | -4,637 | 5,541 |
Cash | 1,025,987 | 1,784 | 4,089 | 8,807 |
Basic Shares | 10,347 | 4,800 | 4,768 | 9,487 |